Eli Lilly To Slash Some Insulin Prices; Expand Cost Cap

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay when they fill prescriptions. The moves promise critical relief to some people with diabetes who can face thousands of dollars a year in bills for insulin they need to live. áLilly’s changes also come as lawmakers pressure drugmakers to do something about soaring prices. Lilly said it will cut the list price for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% in the fourth quarter. The drugmaker didn’t detail the new prices.